MetaCap

Exagen Statistics

NASDAQ: XGNHealth CareMedical SpecialitiesUSD

3.61-0.19 (-5.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Exagen by the numbers

Exagen has a market capitalization of $92.1 million based on 25.51M shares outstanding. With trailing EPS of $-0.76, Exagen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 51.0% below its 50-day average and 29.6% below its 200-day average.

Average daily trading volume is 470.43K shares, or about $1.7 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

XGN valuation vs. peer median

XGN compared with the median of 8 peer companies
MetricXGNPeer medianDifference
Market cap$92.10M$77.91M+18%
Avg. volume470.43K35.62K+1221%

Peer median across 8 companies: KEQU, BDSX, SERA, BNR, TLSI, MDXH, AMS, ACON.

Valuation

Market cap
$92.10M
Price / sales (latest FY)
1.38
EPS (TTM)
$-0.76

Price and trading

Previous close
3.80
Open
3.77
Day range
3.48 – 3.90
52-week range
2.59 – 9.22
52-week change
-52.56%
Beta
—
Volume
508.83K

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
92.10M
Forward Pe
-7.22
Eps
-0.76
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
9.22
Week52 Low
2.59
Avg Volume
470.43K
Shares Outstanding
25.51M
Ma50
7.36
Ma200
5.13
Earnings Date
Nov 10, 2026
Pct From52w High
-60.85%
Pct From52w Low
39.38%

Related